Could Azithromycin Be Part of Pseudomonas aeruginosa Acute Pneumonia Treatment?
Azithromycin (AZM) is a 15-membered-ring macrolide that presents a broad-spectrum antimicrobial activity against Gram-positive bacteria and atypical microorganisms but suffers from a poor diffusion across the outer-membrane of Gram-negative bacilli, including Pseudomonas aeruginosa (PA). However, AZ...
Main Authors: | Anne-Gaëlle Leroy, Jocelyne Caillon, Nathalie Caroff, Alexis Broquet, Stéphane Corvec, Karim Asehnoune, Antoine Roquilly, Lise Crémet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.642541/full |
Similar Items
-
Exoenzyme T Plays a Pivotal Role in the IFN-γ Production after Pseudomonas Challenge in IL-12 Primed Natural Killer Cells
by: Mickael Vourc’h, et al.
Published: (2017-10-01) -
Immune modulation after traumatic brain injury
by: Marwan Bouras, et al.
Published: (2022-12-01) -
CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.
by: Antoine Roquilly, et al.
Published: (2010-01-01) -
Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study
by: Florian Guillotin, et al.
Published: (2022-04-01) -
AZITHROMYCIN IN THERAPY OF BACTERIAL RHINOSINUSITES
by: A. A. Krivopalov, et al.
Published: (2017-07-01)